Cargando…

High-intensity chemotherapy improved the prognosis of patients with high-grade B-cell lymphoma

OBJECTIVE: High-grade B-cell lymphoma (HGBL) is highly aggressive and has a poor prognosis. METHODS: The clinical data of 76 patients with High-grade B-cell lymphoma treated in our lymphoma center from July 2016 to April 2020 were analyzed retrospectively. The clinical features, treatment and progno...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Yanfang, Cai, Qing, Chang, Yu, Zhang, Mingzhi, Li, Zhaoming
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9816475/ https://www.ncbi.nlm.nih.gov/pubmed/36618391 http://dx.doi.org/10.3389/fimmu.2022.1047115

Ejemplares similares

Machine Learning Models for the Diagnosis and Prognosis Prediction of High-Grade B-Cell Lymphoma
por: Kong, Hui, et al.
Publicado: (2022)

High-Grade B-Cell Lymphomas, Not Otherwise Specified: A Study of 41 Cases
por: Li, Jiayin, et al.
Publicado: (2020)

Combination chemotherapy for intermediate and high grade non-Hodgkin's lymphoma.
por: Dhaliwal, H. S., et al.
Publicado: (1993)

Comparison of Chemotherapy Combined With Chidamide Versus Chemotherapy in the Frontline Treatment for Peripheral T-Cell Lymphoma
por: Wang, Jinni, et al.
Publicado: (2022)

The clinical features and prognosis of 100 AIDS-related lymphoma cases
por: Wu, Dedong, et al.
Publicado: (2019)

High CD8(+)tumor-infiltrating lymphocytes indicate severe exhaustion and poor prognosis in angioimmunoblastic T-cell lymphoma
por: Zhu, Qiqi, et al.
Publicado: (2023)

Preclinical and clinical studies of CAR-NK-cell therapies for malignancies
por: Li, Hongwen, et al.
Publicado: (2022)

Salmonella Immunotherapy Improves the Outcome of CHOP Chemotherapy in Non-Hodgkin Lymphoma-Bearing Mice
por: Bascuas, Thais, et al.
Publicado: (2018)

Zanubrutinib plus salvage chemotherapy for relapsed or refractory diffuse large B-cell lymphoma
por: Yuan, Xianggui, et al.
Publicado: (2022)

Follicular lymphoma grade 3B: low grade, high grade or should we skip the grade?
por: Mulvey, Erin, et al.
Publicado: (2023)

An Immune-Related Signature for Predicting the Prognosis of Lower-Grade Gliomas
por: Zhang, Hongbo, et al.
Publicado: (2020)

Low Expression of 14-3-3beta Is Associated With Adverse Survival of Diffuse Large B-Cell Lymphoma Patients
por: Li, Chaoping, et al.
Publicado: (2019)

High-Intensity Chemotherapy is Associated with Better Prognosis in Young Patients with High-Risk Diffuse Large B-Cell Lymphoma: A 10-Year Single-Center Retrospective Cohort Study
por: Ma, Xiaorong, et al.
Publicado: (2016)

Chemotherapy for high-grade gliomas
por: Galanis, E, et al.
Publicado: (2000)

Immunotherapy: A Potential Approach for High-Grade Spinal Cord Astrocytomas
por: Hu, Jie, et al.
Publicado: (2021)

Different Features of Tumor-Associated NK Cells in Patients With Low-Grade or High-Grade Peritoneal Carcinomatosis
por: Pesce, Silvia, et al.
Publicado: (2019)

A Case of Upper Gastrointestinal Bleeding Due to Metastatic High-Grade B-Cell Lymphoma Successfully Treated With Chemotherapy
por: Tanner, Samuel, et al.
Publicado: (2022)

Emerging roles of the gut microbiota in cancer immunotherapy
por: Shi, Zhuangzhuang, et al.
Publicado: (2023)

Deciphering the immune landscape dominated by cancer-associated fibroblasts to investigate their potential in indicating prognosis and guiding therapeutic regimens in high grade serous ovarian carcinoma
por: Li, Yimin, et al.
Publicado: (2022)

Machine learning-based integration develops an immune-related risk model for predicting prognosis of high-grade serous ovarian cancer and providing therapeutic strategies
por: Wu, Qihui, et al.
Publicado: (2023)

Immunogenic cell death-related risk signature predicts prognosis and characterizes the tumour microenvironment in lower-grade glioma
por: Cai, Jiayang, et al.
Publicado: (2022)

Investigating Factors Associated with Thymic Regeneration after Chemotherapy in Patients with Lymphoma
por: Sun, Dao-Ping, et al.
Publicado: (2016)

Significance of NotchScore and JAG1 in predicting prognosis and immune response of low-grade glioma
por: Shi, Bo, et al.
Publicado: (2023)

A 9-LncRNA Signature for Predicting Prognosis and Immune Response in Diffuse Large B-Cell Lymphoma
por: Wang, Xiaoxuan, et al.
Publicado: (2022)

High Densities of Tumor-Associated Plasma Cells Predict Improved Prognosis in Triple Negative Breast Cancer
por: Yeong, Joe, et al.
Publicado: (2018)

Evaluation of costimulatory molecules in dogs with B cell high grade lymphoma
por: Tagawa, Michihito, et al.
Publicado: (2018)

Combined surgery and chemotherapy for the treatment of primary gastrointestinal intermediate- or high-grade non-Hodgkin's lymphomas.
por: Bellesi, G., et al.
Publicado: (1989)

Pediatric versus adult high grade glioma: Immunotherapeutic and genomic considerations
por: Aggarwal, Payal, et al.
Publicado: (2022)

The High Prevalence of Functional Complement Defects Induced by Chemotherapy
por: Keizer, Mischa P., et al.
Publicado: (2016)

Construction and Validation of an Epigenetic Regulator Signature as A Novel Biomarker For Prognosis, Immunotherapy, And Chemotherapy In Hepatocellular Carcinoma
por: Cai, Jialiang, et al.
Publicado: (2022)

PB2277: PROGNOSTIC SIGNIFICANCE OF SERUM MONOCLONAL PROTEINS BASED ON IMMUNOFIXATION ELECTROPHORESIS IN B CELL NON-HODGKIN LYMPHOMA
por: Gao, Yuyang, et al.
Publicado: (2023)

Prognostic role of different PD-L1 expression patterns and tumor-infiltrating lymphocytes in high-grade serous ovarian cancer: a systematic review and meta-analysis
por: Wang, Ye-Min, et al.
Publicado: (2023)

High-Grade Endometrial Stromal Sarcoma: Molecular Alterations and Potential Immunotherapeutic Strategies
por: Kim, Youngah, et al.
Publicado: (2022)

Oncolytic immunovirotherapy for high-grade gliomas: A novel and an evolving therapeutic option
por: Asija, Sweety, et al.
Publicado: (2023)

High HOXA9 gene expression predicts response to chemotherapy and prognosis of high-grade serous ovarian cancer patients
por: Li, Xiao-fei, et al.
Publicado: (2022)

Impact of initial chemotherapy cycles and clinical characteristics on outcomes for HIV-associated diffuse large B cell lymphoma patients: The Central and Western China AIDS Lymphoma League 001 study (CALL-001 study)
por: Wang, Chaoyu, et al.
Publicado: (2023)

Genomic landscape of T-cell lymphoblastic lymphoma
por: Li, Zhaoming, et al.
Publicado: (2022)

Cold Autoimmune Hemolytic Anemia due to High-grade non Hodgkin's B cell Lymphoma with Weak Response to Rituximab and Chemotherapy Regimens
por: Nazel Khosroshahi, Behzad, et al.
Publicado: (2015)

Front-Line Treatment of High Grade B Cell Non-Hodgkin Lymphoma
por: Kesavan, Murali, et al.
Publicado: (2019)

Genetic modification of primary human B cells to model high-grade lymphoma
por: Caeser, Rebecca, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_ll2q9smee9ucb8b7sg1cbktub6